Questcor Pharmaceuticals (NASDAQ: QCOR) had its price target increased by Jefferies Group from $30.00 to $38.00 in a research report released on Wednesday morning. Jefferies Group currently has a buy rating on the stock.
“QCOR beat on the topline and EPS on strong Acthar sales despite seasonal MS softness. While mgmt. expects Q1 headwinds including continued MS softness, inventory draw-down and administrative/distribution changes, it reiterated overall Acthar growth with favorable reimbursement outlook.,” the firm’s analyst wrote.
QCOR has been the subject of a number of other recent research reports. Analysts at Janney Montgomery Scott initiated coverage on shares of Questcor Pharmaceuticals in a research note to investors on Thursday, February 21st. They set a buy rating and a $40.00 price target on the stock. Separately, analysts at TheStreet upgraded shares of Questcor Pharmaceuticals from a hold rating to a buy rating in a research note to investors on Thursday, February 21st. Finally, analysts at Mizuho upgraded shares of Questcor Pharmaceuticals from a neutral rating to a buy rating in a research note to investors on Thursday, February 21st. They now have a $41.00 price target on the stock, up previously from $28.00.
Six research analysts have rated the stock with a buy rating, and three have assigned a hold rating to the company’s stock. Questcor Pharmaceuticals has an average rating of overweight and an average target price of $46.43.
Shares of Questcor Pharmaceuticals traded up 1.23% during mid-day trading on Wednesday, hitting $33.00. Questcor Pharmaceuticals has a 52 week low of $17.25 and a 52 week high of $58.91. The stock’s 50-day moving average is currently $27.4. The company has a market cap of $1.932 billion and a P/E ratio of 10.38.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, April 30th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date of this dividend is Thursday, April 18th. This is a positive change from Questcor Pharmaceuticals’s previous quarterly dividend of $0.20.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
